{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:38Z","timestamp":1790900618727,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201558"],"award-info":[{"award-number":["82201558"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10072-024-07876-z","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:29:13Z","timestamp":1732681753000},"page":"1313-1322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of ofatumumab combined with corticosteroids in the treatment of autoimmune encephalitis: a 6-month cohort study"],"prefix":"10.1007","volume":"46","author":[{"given":"Xiaolan","family":"She","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-7153","authenticated-orcid":false,"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6211-0588","authenticated-orcid":false,"given":"Qinming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"7876_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/practneurol-2020-002567","volume":"21","author":"CE Uy","year":"2021","unstructured":"Uy CE, Binks S, Irani SR (2021) Autoimmune encephalitis: clinical spectrum and management. Pract Neurol 21:412\u2013423. https:\/\/doi.org\/10.1136\/practneurol-2020-002567","journal-title":"Pract Neurol"},{"key":"7876_CR2","doi-asserted-by":"publisher","unstructured":"Nissen MS, Ryding M, Meyer M, Blaabjerg M Autoimmune encephalitis: current knowledge on subtypes, Disease mechanisms and Treatment. CNS & neurological disorders drug targets 2020, 19, 584\u2013598, https:\/\/doi.org\/10.2174\/1871527319666200708133103","DOI":"10.2174\/1871527319666200708133103"},{"key":"7876_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-021-00498-5","volume":"17","author":"MT Cencioni","year":"2021","unstructured":"Cencioni MT, Mattoscio M, Magliozzi R, Bar-Or A, Muraro PA (2021) B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies. Nat Reviews Neurol 17:399\u2013414. https:\/\/doi.org\/10.1038\/s41582-021-00498-5","journal-title":"Nat Reviews Neurol"},{"key":"7876_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biologicals.2020.11.002","volume":"69","author":"K Shah","year":"2021","unstructured":"Shah K, Cragg M, Leandro M, Reddy V (2021) Anti-CD20 monoclonal antibodies in systemic Lupus Erythematosus. Biologicals: J Int Association Biol Stand 69:1\u201314. https:\/\/doi.org\/10.1016\/j.biologicals.2020.11.002","journal-title":"Biologicals: J Int Association Biol Stand"},{"key":"7876_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s00415-021-10744-x","volume":"269","author":"M Margoni","year":"2022","unstructured":"Margoni M, Preziosa P, Filippi M, Rocca MA (2022) Anti-CD20 therapies for multiple sclerosis: current status and future perspectives. J Neurol 269:1316\u20131334. https:\/\/doi.org\/10.1007\/s00415-021-10744-x","journal-title":"J Neurol"},{"key":"7876_CR6","doi-asserted-by":"publisher","unstructured":"Thaler FS, Zimmermann L, Kammermeier S, Strippel C, Ringelstein M, Kraft A, S\u00fchs KW, Wickel J, Geis C, Markewitz R et al (2021) Rituximab Treatment and Long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE Registry. Neurology(R) Neuroimmunol Neuroinflammation 8. https:\/\/doi.org\/10.1212\/nxi.0000000000001088","DOI":"10.1212\/nxi.0000000000001088"},{"key":"7876_CR7","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/ane.13291","volume":"142","author":"G Nepal","year":"2020","unstructured":"Nepal G, Shing YK, Yadav JK, Rehrig JH, Ojha R, Huang DY, Gajurel BP (2020) Efficacy and safety of Rituximab in autoimmune encephalitis: a meta-analysis. Acta Neurol Scand 142:449\u2013459. https:\/\/doi.org\/10.1111\/ane.13291","journal-title":"Acta Neurol Scand"},{"key":"7876_CR8","doi-asserted-by":"publisher","unstructured":"Sanford M, McCormack PL, Ofatumumab (2010) Drugs 70:1013\u20131019. https:\/\/doi.org\/10.2165\/11203850-000000000-00000","DOI":"10.2165\/11203850-000000000-00000"},{"key":"7876_CR9","doi-asserted-by":"publisher","unstructured":"de S\u00e8ze J, Maillart E, Gueguen A, Laplaud DA, Michel L, Thouvenot E, Zephir H, Zimmer L, Biotti D, Liblau R (2023) Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1004795","DOI":"10.3389\/fimmu.2023.1004795"},{"key":"7876_CR10","doi-asserted-by":"publisher","unstructured":"Zhang B, Ofatumumab (2009) mAbs 1, 326\u2013331, https:\/\/doi.org\/10.4161\/mabs.1.4.8895","DOI":"10.4161\/mabs.1.4.8895"},{"key":"7876_CR11","doi-asserted-by":"publisher","first-page":"578062","DOI":"10.1016\/j.jneuroim.2023.578062","volume":"377","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Yin D, Ma J, Chen S (2023) The therapeutic effect of ofatumumab in autoimmune encephalitis: a case series. J Neuroimmunol 377:578062. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578062","journal-title":"J Neuroimmunol"},{"key":"7876_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4103\/aian.aian_236_23","volume":"26","author":"H Xue","year":"2023","unstructured":"Xue H, Jiang Y, Qin L, Wang X, Zhang M, Dai S, Teng Y, Xu J, Li W (2023) Ofatumumab, a fully human Anti-CD20 monoclonal antibody, in the treatment of severe refractory Anti-N-methyl-D-Aspartate receptor encephalitis: two case reports. Ann Indian Acad Neurol 26:774\u2013777. https:\/\/doi.org\/10.4103\/aian.aian_236_23","journal-title":"Ann Indian Acad Neurol"},{"key":"7876_CR13","doi-asserted-by":"publisher","first-page":"4172","DOI":"10.1111\/cns.14416","volume":"29","author":"K Chen","year":"2023","unstructured":"Chen K, Yang L, Xu L, Jiang Y, He J (2023) Ofatumumab for the treatment of refractory anti-LGI1 encephalitis with long-term poor blood glucose control in type 1 diabetes. CNS Neurosci Ther 29:4172\u20134174. https:\/\/doi.org\/10.1111\/cns.14416","journal-title":"CNS Neurosci Ther"},{"key":"7876_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404. https:\/\/doi.org\/10.1016\/s1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"7876_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/0004-282x20170176","volume":"76","author":"LA Dutra","year":"2018","unstructured":"Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R (2018) Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 76:41\u201349. https:\/\/doi.org\/10.1590\/0004-282x20170176","journal-title":"Arq Neuropsiquiatr"},{"key":"7876_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00115-022-01411-1","volume":"94","author":"J Heine","year":"2023","unstructured":"Heine J, Duchow A, Rust R, Paul F, Pr\u00fc\u00df H, Finke C (2023) [Autoimmune encephalitis-An update]. Nervenarzt 94:525\u2013537. https:\/\/doi.org\/10.1007\/s00115-022-01411-1","journal-title":"Nervenarzt"},{"key":"7876_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1007\/s13311-021-01048-z","volume":"18","author":"ES Frisch","year":"2021","unstructured":"Frisch ES, Pretzsch R, Weber MS (2021) A milestone in multiple sclerosis therapy: monoclonal antibodies against CD20-Yet progress continues. Neurotherapeutics: J Am Soc Experimental Neurother 18:1602\u20131622. https:\/\/doi.org\/10.1007\/s13311-021-01048-z","journal-title":"Neurotherapeutics: J Am Soc Experimental Neurother"},{"key":"7876_CR18","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.biopha.2018.11.121","volume":"109","author":"Z Payandeh","year":"2019","unstructured":"Payandeh Z, Bahrami AA, Hoseinpoor R, Mortazavi Y, Rajabibazl M, Rahimpour A, Taromchi AH, Khalil S (2019) The applications of anti-CD20 antibodies to treat various B cells disorders. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie 109:2415\u20132426. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.121","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"7876_CR19","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40263-022-00965-7","volume":"36","author":"L Freeman","year":"2022","unstructured":"Freeman L, Longbrake EE, Coyle PK, Hendin B, Vollmer T (2022) High-efficacy therapies for Treatment-Na\u00efve individuals with relapsing-remitting multiple sclerosis. CNS Drugs 36:1285\u20131299. https:\/\/doi.org\/10.1007\/s40263-022-00965-7","journal-title":"CNS Drugs"},{"key":"7876_CR20","doi-asserted-by":"publisher","unstructured":"Gong X, Zhou D, Hong Z (2023) A novel use and dramatic efficacy of ofatumumab for the treatment of anti-N-methyl-D-aspartate receptor encephalitis: a report of two cases. 16:17562864231161890. https:\/\/doi.org\/10.1177\/17562864231161890","DOI":"10.1177\/17562864231161890"},{"key":"7876_CR21","doi-asserted-by":"publisher","unstructured":"Zhang R, Wang L, Tao Y, Zhang X, Liu K, Song B, Xu Y (2023) The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab. Front Immunol 14. https:\/\/doi.org\/10.3389\/fimmu.2023.1183488","DOI":"10.3389\/fimmu.2023.1183488"},{"key":"7876_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s1474-4422(23)00083-2","volume":"22","author":"J Dalmau","year":"2023","unstructured":"Dalmau J, Graus F (2023) Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease. Lancet Neurol 22:529\u2013540. https:\/\/doi.org\/10.1016\/s1474-4422(23)00083-2","journal-title":"Lancet Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07876-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07876-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07876-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:58:47Z","timestamp":1739559527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07876-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["7876"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07876-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Ruijin Hospital (2021-No.375 on December 13th 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}